Teva MS Drug Patent Backed By UK High Court In Mylan Row
The U.K. High Court of Justice on Monday affirmed the validity of a Teva Pharmaceutical Industries Ltd. patent for its multiple sclerosis drug Copaxone, ruling the patent would be infringed by...To view the full article, register now.
Already a subscriber? Click here to view full article